These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20807885)

  • 1. Cells expressing FLT3/ITD mutations exhibit elevated repair errors generated through alternative NHEJ pathways: implications for genomic instability and therapy.
    Fan J; Li L; Small D; Rassool F
    Blood; 2010 Dec; 116(24):5298-305. PubMed ID: 20807885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective nonhomologous end joining blocks B-cell development in FLT3/ITD mice.
    Li L; Zhang L; Fan J; Greenberg K; Desiderio S; Rassool FV; Small D
    Blood; 2011 Mar; 117(11):3131-9. PubMed ID: 21228325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic instability is a principle pathologic feature of FLT3 ITD kinase activity in acute myeloid leukemia leading to clonal evolution and disease progression.
    Rebechi MT; Pratz KW
    Leuk Lymphoma; 2017 Sep; 58(9):1-11. PubMed ID: 28278729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of WRN and DNA ligase IIIalpha in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks.
    Sallmyr A; Tomkinson AE; Rassool FV
    Blood; 2008 Aug; 112(4):1413-23. PubMed ID: 18524993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pim kinase inhibitor co-treatment decreases alternative non-homologous end-joining DNA repair and genomic instability induced by topoisomerase 2 inhibitors in cells with FLT3 internal tandem duplication.
    Scarpa M; Kapoor S; Tvedte ES; Doshi KA; Zou YS; Singh P; Lee JK; Chatterjee A; Ali MKM; Bromley RE; Hotopp JCD; Rassool FV; Baer MR
    Oncotarget; 2021 Aug; 12(18):1763-1779. PubMed ID: 34504649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine kinase inhibitor-induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitors.
    Maifrede S; Nieborowska-Skorska M; Sullivan-Reed K; Dasgupta Y; Podszywalow-Bartnicka P; Le BV; Solecka M; Lian Z; Belyaeva EA; Nersesyan A; Machnicki MM; Toma M; Chatain N; Rydzanicz M; Zhao H; Jelinek J; Piwocka K; Sliwinski T; Stoklosa T; Ploski R; Fischer T; Sykes SM; Koschmieder S; Bullinger L; Valent P; Wasik MA; Huang J; Skorski T
    Blood; 2018 Jul; 132(1):67-77. PubMed ID: 29784639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partnering with PARP inhibitors in acute myeloid leukemia with FLT3-ITD.
    Dellomo AJ; Baer MR; Rassool FV
    Cancer Lett; 2019 Jul; 454():171-178. PubMed ID: 30953707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML.
    Sallmyr A; Fan J; Datta K; Kim KT; Grosu D; Shapiro P; Small D; Rassool F
    Blood; 2008 Mar; 111(6):3173-82. PubMed ID: 18192505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase-Activated Leukemias.
    Muvarak N; Kelley S; Robert C; Baer MR; Perrotti D; Gambacorti-Passerini C; Civin C; Scheibner K; Rassool FV
    Mol Cancer Res; 2015 Apr; 13(4):699-712. PubMed ID: 25828893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of rare structural chromosome abnormalities at relapse of cytogenetically normal acute myeloid leukemia with FLT3 internal tandem duplication.
    Gourdin TS; Zou Y; Ning Y; Emadi A; Duong VH; Tidwell ML; Chen C; Rassool FV; Baer MR
    Cancer Genet; 2014; 207(10-12):467-73. PubMed ID: 25441683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NADPH oxidase-generated hydrogen peroxide induces DNA damage in mutant FLT3-expressing leukemia cells.
    Stanicka J; Russell EG; Woolley JF; Cotter TG
    J Biol Chem; 2015 Apr; 290(15):9348-61. PubMed ID: 25697362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic instability in myeloid malignancies: increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair.
    Sallmyr A; Fan J; Rassool FV
    Cancer Lett; 2008 Oct; 270(1):1-9. PubMed ID: 18467025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412.
    Seedhouse CH; Hunter HM; Lloyd-Lewis B; Massip AM; Pallis M; Carter GI; Grundy M; Shang S; Russell NH
    Leukemia; 2006 Dec; 20(12):2130-6. PubMed ID: 17066094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internal tandem duplication mutations in the tyrosine kinase domain of FLT3 display a higher oncogenic potential than the activation loop D835Y mutation.
    Marhäll A; Heidel F; Fischer T; Rönnstrand L
    Ann Hematol; 2018 May; 97(5):773-780. PubMed ID: 29372308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Mre11/human Rad50/Nbs1 and DNA ligase IIIalpha/XRCC1 protein complexes act together in an alternative nonhomologous end joining pathway.
    Della-Maria J; Zhou Y; Tsai MS; Kuhnlein J; Carney JP; Paull TT; Tomkinson AE
    J Biol Chem; 2011 Sep; 286(39):33845-53. PubMed ID: 21816818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ku regulates the non-homologous end joining pathway choice of DNA double-strand break repair in human somatic cells.
    Fattah F; Lee EH; Weisensel N; Wang Y; Lichter N; Hendrickson EA
    PLoS Genet; 2010 Feb; 6(2):e1000855. PubMed ID: 20195511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-dependent predominance of nonhomologous DNA end-joining pathways during embryonic development in mice.
    Chiruvella KK; Sebastian R; Sharma S; Karande AA; Choudhary B; Raghavan SC
    J Mol Biol; 2012 Mar; 417(3):197-211. PubMed ID: 22306462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [FMS-like tyrosine kinase 3 gene mutations in acute myeloid leukemia].
    Han YL; Zhang SJ; Qiao C; Dai D; Sun XM; Xu YL; Qian SX; Xu W; Wang JS; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1135-9. PubMed ID: 19840437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA ligase III promotes alternative nonhomologous end-joining during chromosomal translocation formation.
    Simsek D; Brunet E; Wong SY; Katyal S; Gao Y; McKinnon PJ; Lou J; Zhang L; Li J; Rebar EJ; Gregory PD; Holmes MC; Jasin M
    PLoS Genet; 2011 Jun; 7(6):e1002080. PubMed ID: 21655080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FLT3-ITD cooperates with Rac1 to modulate the sensitivity of leukemic cells to chemotherapeutic agents via regulation of DNA repair pathways.
    Wu M; Li L; Hamaker M; Small D; Duffield AS
    Haematologica; 2019 Dec; 104(12):2418-2428. PubMed ID: 30975911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.